Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05374577

Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19)

Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After COVID-19 (PulmVasC)- A Multicenter, Prospective Cohort/Observational Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
University of Giessen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To identify pulmonary vascular disease in post/long-COVID-19 patients as a cause of dyspnea/exercise limitation and to differentiate it from other causes of dyspnea

Detailed description

The aim is to identify pulmonary vascular disease in post/long-COVID-19 patients as a cause of dyspnea/exercise limitation and to differentiate it from other causes of dyspnea (muscular, left cardiac, psychological, deconditioning-related causes) by investigating ventilation-perfusion (V/Q) mismatch and (exercise-induced) pulmonary hypertension (PH) or right heart dysfunction.

Conditions

Interventions

TypeNameDescription
OTHERpulmonary vascular dysfunctionRight ventricular function determined by echocardiography at rest and during exercise (non-invasive estimation of ventilation-perfusion mismatch), systemic endothelial function, left heart function, and plasma levels of vasoactive biomarkers compared with clinical parameters of dyspnea and exercise capacity. Further examinations will be performed in patients with still unclear cause of persistent shortness of breath after 3 months of follow-up (subgroup RHC)
OTHERpulmonary vascular functionRight ventricular function determined by echocardiography at rest and during exercise (non-invasive estimation of ventilation-perfusion mismatch), systemic endothelial function, and plasma levels of vasoactive biomarkers compared with clinical parameters of dyspnea and exercise capacity.

Timeline

Start date
2022-04-15
Primary completion
2025-03-31
Completion
2025-12-01
First posted
2022-05-16
Last updated
2025-09-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05374577. Inclusion in this directory is not an endorsement.